<DOC>
	<DOCNO>NCT01889693</DOCNO>
	<brief_summary>Despite intensive effort , specific athÂ¬erosclerosis-targeting agent label positron emitter yet available . Fortunately , scientist make major advance field clinical atherosclerosis molecular image metabolic PET reporter agent 18F ( fluorine-18 ) -FDG ( Fludeoxyglucose ) apply noninvasively image plaque macrophage carotid artery . However , coronary cerebral arterial segment remain uninterpretable due metabolic property 18F-FDG . Applying character terminal mannose residue MSA bind mannose receptor macrophage atherosclerosis , investigate whether 68Ga-MSA novel agent non-invasive molecular imaging atherosclerotic lesion PET .</brief_summary>
	<brief_title>Imaging Atherosclerosis With 68Ga-MSA</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>acute coronary syndrome ( acute myocardial infarction , unstable angina ) chronic stable angina control without coronary artery disease pregnancy , allergy albumin , chronic inflammatory disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>positron emission tomography</keyword>
	<keyword>macrophage</keyword>
	<keyword>neomannosyl human serum albumin</keyword>
</DOC>